Table 1.
Characteristics of the study participants.
| Characteristics | Women (n=1,255) | Men (n=1,051) |
|---|---|---|
| Demographics | ||
| Age, years | 61.0 (12.0) | 57.9 (12.7) |
| Adiposity Measures | ||
| Upper Body Subcutaneous Fat, cm3 | 309.9 (72.4) | 345.6 (61.7) |
| Body Mass Index, kg/m2 | 27.5 (5.5) | 28.1 (3.8) |
| Neck Circumference, cm | 13.6 (2.7) | 15.9 (1.1) |
| Visceral Adipose Tissue, cm3 | 1,641 (1,026) | 2,936 (1,353) |
| Continuous Cardiometabolic Risk Factors | ||
| Systolic Blood Pressure, mm Hg | 120.2 (16.4) | 123.5 (13.8) |
| Diastolic Blood Pressure, mm Hg | 71.4 (8.9) | 75.7 (9.0) |
| Fasting Plasma Glucose, mg/dL | 96.5 (15.9) | 102.7 (21.0) |
| Total Cholesterol, mg/dL | 195.4 (34.2) | 182.2 (34.7) |
| Triglycerides*, mg/dL | 95.0 (71.0–130.0) | 101.0 (75.0–145.0) |
| HDL Cholesterol, mg/dL | 68.6 (18) | 53.2 (14.4) |
| LDL Cholesterol, mg/dL | 104.9 (30.8) | 105.0 (30.5) |
| Dichotomous Cardiometabolic Risk Factors | ||
| Obesity, % | 27.7 (348) | 26.8 (282) |
| Hypertension, % | 40.2 (504) | 40.4 (425) |
| Impaired Fasting Glucose, % | 28.7 (360) | 46.5 (489) |
| Diabetes Mellitus, % | 7.8 (98) | 11.4 (120) |
| Hypercholesterolemia, % | 38.5 (483) | 43.5 (457) |
| Hypertriglyceridemia, % | 39.4 (495) | 51.7 (543) |
| Low HDL Cholesterol, % | 13.3 (167) | 16.8 (177) |
| High LDL Cholesterol, % | 4.5 (56) | 3.8 (40) |
| Metabolic Syndrome, % | 34.7 (436) | 40.9 (430) |
| Current Smoking, % | 6.1 (77) | 6.6 (69) |
| Alcohol Intake, % | 3.3 (4.9) | 7.0 (8.8) |
| Hypertensive treatment, % | 34.5 (433) | 33.7 (354) |
| Lipid-Lowering Treatment, % | 31.1 (390) | 39.2 (412) |
| Postmenopausal Status, % | 70.5 (885) | – |
| Hormone Replacement Therapy, % | 7.5 (94) | – |
Unless otherwise indicated, continuous variables are described as means (standard deviations) and categorical variables are described as percentages (counts).
*
Described as median (25th–75th percentile) due to the skewed distribution.
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.